e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Polypharmacy in patients hospitalised for acute exacerbation of COPD
Díez-Manglano Jesús, Barquero-Romero José, Mena Pedro Almagro, Recio-Iglesias Jesús, Cabrera-Aguilar Javier, López-García Francisco, Viu Ramón Boixeda, Soriano Joan B., the ECCO Study researchers
Source:
Eur Respir J 2014; 44: 791-794
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Díez-Manglano Jesús, Barquero-Romero José, Mena Pedro Almagro, Recio-Iglesias Jesús, Cabrera-Aguilar Javier, López-García Francisco, Viu Ramón Boixeda, Soriano Joan B., the ECCO Study researchers. Polypharmacy in patients hospitalised for acute exacerbation of COPD. Eur Respir J 2014; 44: 791-794
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Polypharmacy in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - COPD management
Year: 2011
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
The validity of the EQ5D5L in patients hospitalized an acute exacerbation of COPD
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
The rationality of the use of NIV in elderly patients with acute COPD exacerbation
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
High-risk patients following hospitalisation for an acute exacerbation of COPD
Source: Eur Respir J 2013; 42: 946-955
Year: 2013
Quantification of severity of the acute exacerbation in hospitalized COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 559s
Year: 2003
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Underdiagnosis of COPD in hospitalized patients
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
Determinants of 6-months mortality in elderly patients admitted for non-acidotic acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD.
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Anemia in COPD patients with an exacerbation
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Impact of diabetes in patients admitted with acute exacerbation of COPD
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?
Source: ERJ Open Res, 7 (3) 00362-2021; 10.1183/23120541.00362-2021
Year: 2021
Prognosis after hospitalization for acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Cognitive impairment in patients hospitalized with acute COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Characteristics and outcome of COPD patients with an acute exacerbation admited to a respiratory ICU
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept